Gene testing war looms for AstraZeneca heart drug
Gene testing is shaping up to be a marketing battleground for new blood thinners like AstraZeneca’s Brilinta, underscoring the power and limitations of genetics as a tool to predict medical outcomes.

Read more on Reuters via Yahoo! News

Sport Health World

• New Study of Clinical Trials Links Diabetes Drug Avandia with Heart Attack Risk
• What are the conditions that cause a sudden heart attack could not pick an electrocardiogram?
• What are the main causes of heart disease?
• What is the approximate amount of care for dog diseases like heart disease, heart worm, or pneumonia?
• Known heart disease!
• Heal a broken heart
• What drug companies do not tell you and your doctor does not know: Alternative treatments that can change your life – and the requirements that could affect you notice
• Understanding the risk factors for heart disease
• What is the best diet for people with heart disease, stroke and blood disorders?